ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11248065.
- Also identified by PMC identifier 30640.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
DPC4 is known to mediate signals initiated by type beta transforming growth factor (TGFbeta) as well as by other TGFbeta superfamily ligands such as activin and BMP (bone morphogenic proteins), but mutational surveys of such non-TGFbeta receptors have been negative to date. Here we describe the gene structure and novel somatic mutations of the activin type I receptor, ACVR1B, in pancreatic cancer. ACVR1B has not been described previously as a mutated tumor-suppressor gene.
Medical subject headings
- Activin Receptors, Type I
- Adenocarcinoma
- Mutation
- Pancreatic Neoplasms
- Proteins